.海力特治疗慢性乙型肝炎临床观察[J].中国海洋药物,1996,15(1):36-38.
海力特治疗慢性乙型肝炎临床观察
A CLINICAL OBSERVATION ON HAILITE(HLT) IN TREATING CHRONIC HEPATITIS B
  
DOI:
中文关键词:  海力特 乙型肝炎 药物疗法
English Keywords:Hai Li Te (HLT),chronic hepatitis B,treatment,
Fund Project:
摘要点击次数: 2918
全文下载次数: 38
中文摘要:
      采用海洋药物海力特治疗慢性乙型肝炎25例,并与猪苓多糖加乙肝疫苗治疗作为对照。结果表明,海力特治疗慢性乙型肝炎总有效率为88.0%,ALT复常率86.96%,HBeAg转阴率40.91%,与猪苓多糖加乙肝疫苗的疗效无显著性差异(P>0.05)。
English Summary:
      Twenty five patients with chronic hepatitis B were treated with a new marine drug HAILITE (HLT) ,and compared with a control group treated with Zhuling Duotang. The results showed that the total effective rate of the treating group (HLT) was 88. 0 per cents.the recovery rate of ALT was 86. 96 percents.and the rate of HBeAg returning negative. 40. 91 per cents. There was no significant difference between the two groups ( P >0. 05).
查看全文  查看/发表评论  下载PDF阅读器
关闭